Moreover, Park & al. demonstrated in MCF10 breast cancer cells overexpressing SRSF6 that ITGA5, ITGB2 and ITGB6 were overexpressed and alternative splicing variants of ITGB2, ITGB4, SRSF6 and ATXN2 were detected. This evidence concerns the gene ATXN2 and breast carcinoma.